Medical device manufacturer Amsino International Inc announced on Thursday that it has been awarded a contract by healthcare company Vizient for enteral syringes, effective 1 August 2026.

Amsino manufactures enteral syringes in both North America and overseas, supporting a dual-source manufacturing strategy designed to enhance supply continuity and reduce risk for healthcare providers. The programme leverages manufacturing redundancies across multiple facilities to strengthen supply chain resiliency and help ensure uninterrupted product availability during periods of market volatility or disruption.

Amsino's enteral syringe portfolio is designed to support safe and efficient enteral medication delivery and feeding practices across a variety of clinical settings.